EURICAN DAPPi-L

Land: Kroatien

Sprache: Kroatisch

Quelle: Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

Wirkstoff:

Liofilizat:; Atenuirani virus štenećaka, soj BA5 ; Atenuirani adenovirus pasa CAV2, soj DK13 ; Atenuirani parvovirus pasa, soj CAG2 ; Atenuirani virus parainfluence tip 2, soj CGF 2004/75; ; Suspenzija:; Inaktivirana Leptospira interrogans serogrupa i serovar Canicola, soj 16070;; Inaktivirana Leptospira interrogans serogrupa i serovar Icterohaemorrhagiae, soj 16069

Verfügbar ab:

Boehringer Ingelheim Animal Health France SCS, 29 Avenue Tony Garnier, 69007 Lyon, Francuska

ATC-Code:

QI07AI02

INN (Internationale Bezeichnung):

Liofilizat:; Atenuirani virus štenećaka, strain BA5 ; Atenuirani adenovirus dogs codes cav2, strain DK13 ; Atenuirani the canine parvovirus, strain CAG2 ; Atenuirani parainfluence virus type 2 strain CGF 2004/75; ; Mounting:; Inaktivirana serogrupa and Leptospira interrogans serovar Canicola strain 16070;; Inaktivirana serogrupa and Leptospira interrogans serovar Icterohaemorrhagiae strain 16069

Darreichungsform:

liofilizat i suspenzija za suspenziju za injekciju

Verschreibungstyp:

DA

Hergestellt von:

DDL ZAGREB d.o.o., Abramovićeva 11, 10000 Zagreb, Hrvatska

Therapiegruppe:

pasa

Therapiebereich:

živo virusno i inaktivirano bakterijsko cjepivo

Berechtigungsstatus:

Vrijedi

Berechtigungsdatum:

2017-07-19